2022
DOI: 10.1530/endoabs.81.ep1024
|View full text |Cite
|
Sign up to set email alerts
|

TSHR promoter methylation level changes as a prognostic blood-based biomarker in follicular thyroid carcinoma

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles